Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
$2.69
As of 03/04/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.